In the placebo group , participants with a high homocysteine level ( n = 588 ) had a 1.8 higher risk ( 95 % confidence interval ( CI ) = 1.2-2 .5 , P = .001 ) of fatal and nonfatal CHD than those with a low homocysteine level ( n = 597 ) .